4-113357727-A-G
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_001148.6(ANK2):c.9109A>G(p.Lys3037Glu) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K3037R) has been classified as Uncertain significance.
Frequency
Consequence
NM_001148.6 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, ClinGen
- Brugada syndromeInheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Genomics England PanelApp, ClinGen
- catecholaminergic polymorphic ventricular tachycardiaInheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp
- heart conduction diseaseInheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
- neurodevelopmental disorderInheritance: AD Classification: LIMITED Submitted by: G2P
- cardiac arrhythmia, ankyrin-B-relatedInheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- long QT syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001148.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ANK2 | NM_001148.6 | MANE Select | c.9109A>G | p.Lys3037Glu | missense | Exon 38 of 46 | NP_001139.3 | ||
| ANK2 | NM_001386174.1 | c.9250A>G | p.Lys3084Glu | missense | Exon 40 of 51 | NP_001373103.1 | |||
| ANK2 | NM_001386175.1 | c.9226A>G | p.Lys3076Glu | missense | Exon 39 of 50 | NP_001373104.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ANK2 | ENST00000357077.9 | TSL:1 MANE Select | c.9109A>G | p.Lys3037Glu | missense | Exon 38 of 46 | ENSP00000349588.4 | ||
| ANK2 | ENST00000506344.6 | TSL:1 | c.9250A>G | p.Lys3084Glu | missense | Exon 40 of 51 | ENSP00000422888.2 | ||
| ANK2 | ENST00000394537.7 | TSL:1 | c.4427-3096A>G | intron | N/A | ENSP00000378044.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000399 AC: 1AN: 250628 AF XY: 0.00000738 show subpopulations
GnomAD4 exome Cov.: 35
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Long QT syndrome Uncertain:1
In summary, this variant is a rare missense change that is not predicted to affect protein function. There is no indication that it causes disease, but the available evidence is currently insufficient to prove that conclusively. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies. This variant is present in population databases (rs768741443, ExAC 0.002%) but has not been reported in the literature in individuals with a ANK2-related disease. This sequence change replaces lysine with glutamic acid at codon 3037 of the ANK2 protein (p.Lys3037Glu). The lysine residue is moderately conserved and there is a small physicochemical difference between lysine and glutamic acid.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at